ISU College of Veterinary Medicine to Conduct a Study with Immunocidin® in the Treatment of Canine Hemangiosarcoma
NovaVive's anticancer immunotherapeutic for dogs will be evaluated in a clinical study at Iowa State University (ISU) College of Veterinary Medicine in the treatment of splenic hemangiosarcoma (in combination with chemo).
It's World Antibiotic Awareness Week and NovaVive is doing its part to help address the concern about antibiotic resistance by offering antibiotic alternatives for animals to the veterinary community and livestock/pet owners.
Amplimune® Receives Canadian OMRI Listing for Use in Organic Cattle Production
The Company's regulator-approved immunotherapy for calf scours, Amplimune®, has received an Organic Materials Review Institute (OMRI) Listing in Canada. This means that Amplimune may be used in organic cattle production.